These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31501115)

  • 1. Development of core outcome sets for vision screening and assessment in stroke: a Delphi and consensus study.
    Rowe FJ; Hepworth LR; Kirkham JJ
    BMJ Open; 2019 Sep; 9(9):e029578. PubMed ID: 31501115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of core outcome sets and core outcome measures for central visual impairment, visual field loss and ocular motility disorders due to stroke: a Delphi and consensus study.
    Rowe FJ; Hepworth LR; Kirkham JJ
    BMJ Open; 2022 Mar; 12(3):e056792. PubMed ID: 35304397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Delphi methodology in the development of a new patient-reported outcome measure for stroke survivors with visual impairment.
    Hepworth LR; Rowe FJ
    Brain Behav; 2018 Feb; 8(2):e00898. PubMed ID: 29484260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vision Screening Assessment (VISA) tool: diagnostic accuracy validation of a novel screening tool in detecting visual impairment among stroke survivors.
    Rowe FJ; Hepworth L; Howard C; Bruce A; Smerdon V; Payne T; Jimmieson P; Burnside G
    BMJ Open; 2020 Jun; 10(6):e033639. PubMed ID: 32532765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual Impairment Screening Assessment (VISA) tool: pilot validation.
    Rowe FJ; Hepworth LR; Hanna KL; Howard C
    BMJ Open; 2018 Mar; 8(3):e020562. PubMed ID: 29511021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A protocol for the Development of Core Outcome Sets for Endodontic Treatment modalities (COSET): an international consensus process.
    El Karim IA; Duncan HF; Cushley S; Nagendrababu V; Kirkevang LL; Kruse C; Chong BS; Shah PK; Lappin M; McLister C; Lundy FT; Clarke M
    Trials; 2021 Nov; 22(1):812. PubMed ID: 34789318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Practice in Care Provision for Post-stroke Visual Impairment.
    Rowe FJ
    Strabismus; 2017 Sep; 25(3):112-119. PubMed ID: 28759299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Core Outcome Set for Clinical Trials in Non-infectious Uveitis of the Posterior Segment.
    Tallouzi MO; Mathers JM; Moore DJ; Bucknall N; Calvert MJ; Murray PI; Denniston AK;
    Ophthalmology; 2021 Aug; 128(8):1209-1221. PubMed ID: 33515595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Core outcome set for three ophthalmic conditions: a healthcare professional and patient consensus on core outcome sets for amblyopia, ocular motility and strabismus (COSAMS Study).
    Al-Jabri S; Rowe FJ; Kirkham JJ
    BMJ Open; 2021 May; 11(5):e042403. PubMed ID: 33980515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening methods for post-stroke visual impairment: a systematic review.
    Hanna KL; Hepworth LR; Rowe F
    Disabil Rehabil; 2017 Dec; 39(25):2531-2543. PubMed ID: 27669628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual perceptual deficit screening in stroke survivors: evaluation of current practice in the United Kingdom and Republic of Ireland.
    Colwell MJ; Demeyere N; Vancleef K
    Disabil Rehabil; 2022 Nov; 44(22):6620-6632. PubMed ID: 34455876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a core outcome set for evaluative research into paediatric cerebral visual impairment (CVI), in the UK and Eire.
    Pease A; Goodenough T; Borwick C; Watanabe R; Morris C; Williams C
    BMJ Open; 2021 Sep; 11(9):e051014. PubMed ID: 34588256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core Outcome Set-STAndards for Development: The COS-STAD recommendations.
    Kirkham JJ; Davis K; Altman DG; Blazeby JM; Clarke M; Tunis S; Williamson PR
    PLoS Med; 2017 Nov; 14(11):e1002447. PubMed ID: 29145404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vision In Stroke cohort: Profile overview of visual impairment.
    Rowe FJ;
    Brain Behav; 2017 Nov; 7(11):e00771. PubMed ID: 29201538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a patient reported outcome measures for measuring the impact of visual impairment following stroke.
    Hepworth LR; Rowe FJ; Burnside G
    BMC Health Serv Res; 2019 May; 19(1):348. PubMed ID: 31151449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Care provision for poststroke visual impairment.
    Rowe FJ; Walker M; Rockliffe J; Pollock A; Noonan C; Howard C; Glendinning R; Feechan R; Currie J
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1131-44. PubMed ID: 25920755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COS-Speech: protocol to develop a core outcome set for dysarthria after stroke for use in clinical practice and research.
    Mitchell C; Bowen A; Conroy P; Whelan BM; Wallace SJ; Dancer A; Woodward-Nutt K; Kirkham JJ
    Trials; 2023 Jan; 24(1):57. PubMed ID: 36698201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of visual impairment following stroke (IVIS study): a prospective clinical profile of central and peripheral visual deficits, eye movement abnormalities and visual perceptual deficits.
    Rowe FJ; Hepworth LR; Howard C; Hanna KL; Currie J
    Disabil Rehabil; 2022 Jun; 44(13):3139-3153. PubMed ID: 33347793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International consensus recommendations for outcome measurement in post-stroke arm rehabilitation trials.
    Duncan Millar J; VAN Wijck F; Pollock A; Ali M
    Eur J Phys Rehabil Med; 2021 Feb; 57(1):61-68. PubMed ID: 33215905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting.
    Lang KM; Harrison KL; Williamson PR; Huntly BJP; Ossenkoppele G; Geissler J; Bereczky T; Hernández-Rivas JM; Chevrou-Séverac H; Goodbody R; Schulze-Rath R; Bullinger L
    Trials; 2020 May; 21(1):437. PubMed ID: 32460828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.